Celgene: Fears Are Overplayed
Me quedo con esto...
Any company buying back a lot of stock always catches my attention. A stock has to be cheap and the balance sheet strong in order for a company to repurchase a large amount of the outstanding stock. Celgene fits the equation after announcing another $3 billion buyback plan while the stock trades at multi-year lows.